XBiotech (NASDAQ:XBIT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does XBiotech (XBIT) operate in?

XBiotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

XBiotech Stock (NASDAQ: XBIT) stock price, news, charts, stock research, profile.

Open	$7.05
Close	$6.66
Volume / Avg.	95.51K / 48.71K
Day Range	$6.61 - $7.17
52 Wk Range	3.51 - 9.96
Market Cap	$202.88M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	4.76%
Days to Cover	19.9

Recent News

What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday?

XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin regimen.

Vandana Singh

Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers

Lisa Levin

Dow Jumps Over 100 Points; US Housing Starts Rise In April

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.37% to 33,135.37 while the NASDAQ rose 0.39% to 12,391.68. The S&P 500, also rose, gaining, 0.45% to 4,128.33.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$7.05
Close	$6.66
Volume / Avg.	95.51K / 48.71K
Day Range	$6.61 - $7.17
52 Wk Range	3.51 - 9.96
Market Cap	$202.88M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	4.76%
Days to Cover	19.9

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy XBiotech (XBIT) stock?

You can purchase shares of XBiotech (NASDAQ:XBIT) through any online brokerage.

View our list of the best stock brokerages

Who are XBiotech (XBIT) competitors?

Other companies in XBiotech’s space includes: Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), Inozyme Pharma (NASDAQ:INZY), Fate Therapeutics (NASDAQ:FATE) and Kyverna Therapeutics (NASDAQ:KYTX).

What is the forecast, or price target, for XBiotech (XBIT) stock?

There is no analysis for XBiotech to provide a consensus price target.

What is the current price for XBiotech (XBIT)?

The stock price for XBiotech (NASDAQ: XBIT) is $6.66 last updated November 15, 2024 at 4:00 PM EST.

Does XBiotech (XBIT) pay a dividend?

There are no upcoming dividends for XBiotech.

When is XBiotech (NASDAQ:XBIT) reporting earnings?

XBiotech’s Q3 earnings are confirmed for Friday, November 29, 2024.

Is XBiotech (XBIT) going to split?

There is no upcoming split for XBiotech.

What sector and industry does XBiotech (XBIT) operate in?

XBiotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

XBiotech

XBiotech (XBIT) Forecast